News

Vertex Pharmaceutical Stock Dives as Firm to Stop Developing Acute Pain Drug
Shares of Vertex Pharmaceuticals sank 15% after the drugmaker announced a study showed its experimental pain medicine was not ...
The hair loss treatment that takes just 90 SECONDS - and it's FDA-cleared, drug-free, and $150 off today: 'Never seen new growth like this until now!'
SHOPPING: Experience powerful, science-backed solutions for hair regrowth with these innovative devices that are drug-free, ...
Hims & Hers Q2 Earnings - Wall Street Sells Despite GLP Compounding Promises
Hims & Hers delivered strong Q2 growth, driven by compounded GLP-1 offerings, but faces uncertainty as regulatory and supply ...